Dear Colleagues and Friends,

On behalf of the organizing committee, it is my great pleasure to announce that the International Symposium in Quantitative Pharmacology (ISQP) will be held on December, 2017, Beijing, China.

The integration of PK and PD modeling and simulation have played a vital role to guide the decision making process on optimization and product realization, virtually in every stage to reduce time and cost needed for drug development.

With the recent trend toward global drug development and clinical trials, China has been regarded as the next frontier for the pharmaceutical industry. Pfizer, Roche, Johnson & Johnson, GSK, Novartis and others have established Research and Development (R&D) centers in China. Also, through the government support, the pharmaceutical industry and related infrastructure have been growing rapidly in China.

The success of previous three ISQPs since 2007 in China has created a big momentum in promoting the related research in this field in China. We believe that ISQP Beijing 2017 will also lend a platform for the scientific leaders in academia, regulatory authority and the pharmaceutical industry. It will be an opportunity to discuss the opportunities and challenges ahead in global drug research and development. We hope this symposium will contribute to enhance exchanging mutual interests between Western and China in this very challenging area.

As the capital of China with a history for more than 3000 years, Beijing, a rapidly changing city will present you a cultural experience with a mixture of old tradition and hi-technology during the stay.

Thank you in advance for your participation and support.

Pei Hu, PhD
President of the Organizing Committee
Professor, Director
Phase I Unit, Clinical Pharmacology Research Center, Peking Union Medical College Hospital and Chinese Academy of Medical Science